HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 201–300 of 1,012
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Yang, K., Song, Y., Xie, H., Wu, H., Wu, Y.-T., Leisten, E. D., & Tang, W. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.057 · Cited by 190
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Porter, N. J., Mahendran, A., Breslow, R., & Christianson, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718823114 · Cited by 190
“One of these domains, CD2, catalyzes the deacetylation of K40 of α-tubulin in the lumen of the microtubule (29, 30).”
BackgroundHDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy
Krukowski, K., Ma, J., Golonzhka, O., Laumet, G. O., Gutti, T., van Duzer, J. H., Mazitschek, R., Jarpe, M. B., Heijnen, C. J., & Kavelaars, A. (2017) · Pain · doi:10.1097/j.pain.0000000000000893 · Cited by 186
“Indeed, increased acetylation of a-tubulin by HDAC6 inhibition is associated with improved mitochondrial transport.(14,16,22) In our model of cisplatin-induced peripheral neuropathy, we show that inhibition of HDAC6 with ACY-1083 promoted a-tubulin acetylation (Fig.”
InfluentialMai, A., Massa, S., Pezzi, R., Simeoni, S., Rotili, D., Nebbioso, A., Scognamiglio, A., Altucci, L., Loidl, P., & Brosch, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049002a · Cited by 184
Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma
Sakuma, T., Uzawa, K., Onda, T., Shiiba, M., Yokoe, H., Shibahara, T., & Tanzawa, H. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.117 · Cited by 185
“deacetylates ·-tubulin in polymerized microtubules, thus potentially enhancing chemotactic cell motility (19,20).”
BackgroundLo, P.-K., & Sukumar, S. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1879 · Cited by 184
Rettig, I., Koeneke, E., Trippel, F., Mueller, W. C., Burhenne, J., Kopp-Schneider, A., Fabian, J., Schober, A., Fernekorn, U., von Deimling, A., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.24 · Cited by 180
Bali, P., Pranpat, M., Swaby, R., Fiskus, W., Yamaguchi, H., Balasis, M., Rocha, K., Wang, H.-G., Richon, V., & Bhalla, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0344 · Cited by 184
Posttranslational Modifications of Tubulin and Cilia
Wloga, D., Joachimiak, E., Louka, P., & Gaertig, J. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028159 · Cited by 183
Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
Mak, A. B., Nixon, A. M. L., Kittanakom, S., Stewart, J. M., Chen, G. I., Curak, J., Gingras, A.-C., Mazitschek, R., Neel, B. G., Stagljar, I., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.016 · Cited by 183
“Unlike other histone deacetylases, HDAC6 is primarily cytoplasmic, associated with microtubules and dynein motors, and directly regulates the acetylation state of α-tubulin at lysine 40 through its deacetylase activity (Hubbert et al., 2002; Zhang et al., 2003, 2006).”
BackgroundSelf-citationEffects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure
Howes, S. C., Alushin, G. M., Shida, T., Nachury, M. V., & Nogales, E. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0387 · Cited by 183
“Histone deacetylase 6 (HDAC6) and sirtuin 2 (SIRT2) both have deacetylase activity for αK40 (Hubbert et al., 2002; North et al., 2003) and localize to the cytoplasm rather than the nucleus.”
BackgroundHistone deacetylases—an important class of cellular regulators with a variety of functions
Hildmann, C., Riester, D., & Schwienhorst, A. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0911-2 · Cited by 180
“Making use of its second catalytic domain, HDAC6 deacetylates and, thereby, regulates the function of α-tubulin (Hubbert et al. 2002; Zhang et al. 2003) and of molecular chaperone Hsp90 as well as of glucocorticoid receptor (Bali et al. 2005; Kovacs et al. 2005).”
BackgroundPegtel, D. M., Ellenbroek, S. I. J., Mertens, A. E. E., van der Kammen, R. A., de Rooij, J., & Collard, J. G. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.035 · Cited by 183
“In addition, blocking the posttranslational modification of MTs compromises their stability and reduces chemotactic migration [33].”
BackgroundEpigenetic control of plant immunity
ALVAREZ, M. E., NOTA, F., & CAMBIAGNO, D. A. (2010) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2010.00621.x · Cited by 181
“However, transcription factors, cytoskeletal proteins, proteins involved in DNA repair and others are also substrates of HDACs (Cohen et al., 2004; Glozak et al., 2005; Hubbert et al., 2002; Juan et al., 2000).”
BackgroundTau – an inhibitor of deacetylase HDAC6 function
Perez, M., Santa‐Maria, I., De Barreda, E. G., Zhu, X., Cuadros, R., Cabrero, J. R., Sanchez‐Madrid, F., Dawson, H. N., Vitek, M. P., Perry, G., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06102.x · Cited by 182
“As HDAC6 is the main tubulin deacetylase (Hubbert et al. 2002), in the presence of tau which inhibits the deacetylation of tubulin, the level of tubulin acetylation should increase as we observed.”
BackgroundSudo, H., & Baas, P. W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0048-10.2010 · Cited by 181
“HDAC6, a histone deacetylase that is specific for tubulin, has been reported to cause global deacetylation of microtubules when overexpressed in cells (Hubbert et al., 2002; Zhao et al., 2010).”
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
Wu, H., Yang, K., Zhang, Z., Leisten, E. D., Li, Z., Xie, H., Liu, J., Smith, K. A., Novakova, Z., Barinka, C., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00516 · Cited by 180
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
Liu, T., Wan, Y., Xiao, Y., Xia, C., & Duan, G. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00491 · Cited by 186
The emerging role of acetylation in the regulation of autophagy
Bánréti, Á., Sass, M., & Graba, Y. (2013) · Autophagy · doi:10.4161/auto.23908 · Cited by 164
Clarke, J. D., Hsu, A., Yu, Z., Dashwood, R. H., & Ho, E. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000547 · Cited by 177
“Tubulin is a well-known deacetylation target for HDAC6 and this process has an impact on microtubule dynamics [11, 13].”
Wickström, S. A., Masoumi, K. C., Khochbin, S., Fässler, R., & Massoumi, R. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.317 · Cited by 175
“…European Molecular Biology Organization The EMBO Journal VOL 29 | NO 1 | 2010 EMBO THE JOURNAL 131 2009), while HDAC6 (histone deacetylase-6) and SIRT2 (the Silent Information Regulator Type-2) have been shown to deacetylate a-tubulin (Hubbert et al, 2002; North et al, 2003).”
BackgroundMethodInfluentialRequirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
Shan, B., Yao, T.-P., Nguyen, H. T., Zhuo, Y., Levy, D. R., Klingsberg, R. C., Tao, H., Palmer, M. L., Holder, K. N., & Lasky, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802786200 · Cited by 172
Self-citationRegulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6
Lissanu Deribe, Y., Wild, P., Chandrashaker, A., Curak, J., Schmidt, M. H. H., Kalaidzidis, Y., Milutinovic, N., Kratchmarova, I., Buerkle, L., Fetchko, M. J., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000576 · Cited by 60
“Antibodies and other reagents Antibodies against HDAC6 (15) and against EGFR (37) were previously described.”
BackgroundSoluble levels of cytosolic tubulin regulate ciliary length control
Sharma, N., Kosan, Z. A., Stallworth, J. E., Berbari, N. F., & Yoder, B. K. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0269 · Cited by 173
“Tubacin is a highly selective inhibitor of HDAC6, an enzyme that is responsible for deacetylation of α-tubulin both in vitro and in vivo (Hubbert et al., 2002).”
BackgroundHDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization
Li, Y., Zhang, X., Polakiewicz, R. D., Yao, T.-P., & Comb, M. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c700185200 · Cited by 173
Self-citationGibbs, A., Schwartzman, J., Deng, V., & Alumkal, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908908106 · Cited by 172
“LNCaP cells were transfected with siRNA by using DharmaFECT 3 transfection reagent for a final concentration of 100 nM (Dharmacon) (14).”
MethodGarnham, C. P., & Roll‐Mecak, A. (2012) · Cytoskeleton · doi:10.1002/cm.21027 · Cited by 172
“For example, knock-down of HDAC6 in NIH-3T3 cells increases their motility [Hubbert et al., 2002] and since HDAC6 localizes to the leading edge of fibroblasts, a highly dynamic environment without microtubules enriched in acetylation, HDAC6 was proposed to regulate cell motility by controlling…”
BackgroundInfluentialEssential role of HDAC6 in the regulation of PD‐L1 in melanoma
Lienlaf, M., Perez-Villarroel, P., Knox, T., Pabon, M., Sahakian, E., Powers, J., Woan, K. V., Lee, C., Cheng, F., Deng, S., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.012 · Cited by 170
Gallo, P., Latronico, M. V. G., Gallo, P., Grimaldi, S., Borgia, F., Todaro, M., Jones, P., Gallinari, P., De Francesco, R., Ciliberto, G., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn215 · Cited by 170
Hyttinen, J. M. T., Amadio, M., Viiri, J., Pascale, A., Salminen, A., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.002 · Cited by 170
Zhang, D., Wu, C.-T., Qi, X., Meijering, R. A. M., Hoogstra-Berends, F., Tadevosyan, A., Cubukcuoglu Deniz, G., Durdu, S., Akar, A. R., Sibon, O. C. M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005300 · Cited by 169
Jochems, J., Boulden, J., Lee, B. G., Blendy, J. A., Jarpe, M., Mazitschek, R., Van Duzer, J. H., Jones, S., & Berton, O. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.207 · Cited by 166
“All rights reserved 0893-133X/14 www.neuropsychopharmacology.org best-characterized substrate of HDAC6 is a-tubulin (Hubbert et al, 2002), with a number of other HDAC6 substrates identified, including Hsp90 (Kovacs et al, 2005), cortactin (Zhang et al, 2007), and beta-catenin (Li et al, 2008).”
Development of vorinostat: Current applications and future perspectives for cancer therapy
Richon, V. M., Garcia-Vargas, J., & Hardwick, J. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.002 · Cited by 169
“In addition to the transcriptional effects of vorinostat through enhanced histone acetylation, increased acetylation of transcription factors such as p53 [41], HIF-1a [42,43], and E2F [44] and increased acetylation of cytoplasmic proteins such as a-tubulin [45], cortactin [19], and HSP90 [21,19,46] also contribute to…”
BackgroundGao, Y.-S., Hubbert, C. C., & Yao, T.-P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042754 · Cited by 167
Self-citationZhou, Q., Agoston, A. T., Atadja, P., Nelson, W. G., & Davidson, N. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0330 · Cited by 167
“example is the microtubule-associated deacetylase, HDAC6, which is localized largely in the cytoplasm and seems to be important in microtubule acetylation and chemotactic cell motility (19-21).”
BackgroundInfluentialRecent Advances in the Development of Polyamine Analogues as Antitumor Agents
Casero, R. A., & Woster, P. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900187v · Cited by 166
Neugebauer, R. C., Uchiechowska, U., Meier, R., Hruby, H., Valkov, V., Verdin, E., Sippl, W., & Jung, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700972e · Cited by 166
Perico, L., Morigi, M., Rota, C., Breno, M., Mele, C., Noris, M., Introna, M., Capelli, C., Longaretti, L., Rottoli, D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00937-2 · Cited by 164
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders
Hahnen, E., Hauke, J., Tränkle, C., Eyüpoglu, I. Y., Wirth, B., & Blümcke, I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.169 · Cited by 165
“HDAC6 has shown to be nearly resistant to VPA, PB, SNDX-275 and apicidin, and displays a comparatively low susceptibility against romidepsin [8,14,62,63] .”
BackgroundMurphy, P. J. M., Morishima, Y., Kovacs, J. J., Yao, T.-P., & Pratt, W. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506997200 · Cited by 164
Self-citationThe cytoskeleton in spermatogenesis
Dunleavy, J. E. M., O’Bryan, M. K., Stanton, P. G., & O’Donnell, L. (2019) · Reproduction · doi:10.1530/rep-18-0457 · Cited by 161
Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
Ran, J., Yang, Y., Li, D., Liu, M., & Zhou, J. (2015) · Scientific Reports · doi:10.1038/srep12917 · Cited by 159
Tubulin Post-Translational Modifications and Microtubule Dynamics
Wloga, D., Joachimiak, E., & Fabczak, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102207 · Cited by 161
“For example, HDAC6-dependent deacetylation of both α-tubulin and cortactin leads to cilia disassembly [36].”
BackgroundInfluentialInhibition of Histone Deacetylation: A Strategy for Tumor Radiosensitization
Camphausen, K., & Tofilon, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6202 · Cited by 162
The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis
Li, Y., Wei, Q., Zhang, Y., Ling, K., & Hu, J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200912001 · Cited by 162
Zhang, X.-H., Qin-Ma, Wu, H.-P., Khamis, M. Y., Li, Y.-H., Ma, L.-Y., & Liu, H.-M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01782 · Cited by 143
Two Catalytic Domains Are Required for Protein Deacetylation
Zhang, Y., Gilquin, B., Khochbin, S., & Matthias, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500241200 · Cited by 160
Li, Z., & Zhu, W.-G. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9067 · Cited by 160
“HDAC6 interacts and deacetylates tubulin [160, 161].”
Role of the Tetradecapeptide Repeat Domain of Human Histone Deacetylase 6 in Cytoplasmic Retention
Bertos, N. R., Gilquin, B., Chan, G. K. T., Yen, T. J., Khochbin, S., & Yang, X.-J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408583200 · Cited by 160
Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158
The role of histone deacetylases in prostate cancer
Abbas, A., & Gupta, S. (2008) · Epigenetics · doi:10.4161/epi.3.6.7273 · Cited by 167
Regulating the Regulators: The Post‐Translational Code of Class I HDAC1 and HDAC2
Segré, C. V., & Chiocca, S. (2011) · BioMed Research International · doi:10.1155/2011/690848 · Cited by 153
“Class II HDAC6 is the main cytosolic deacetylase controlling the cytoskeleton dynamics and chaperone functions through acetylation of α-tubulin and HSP90, respectively [11, 12].”
Histone deacetylase 4 is required for TGFβ1-induced myofibroblastic differentiation
Glenisson, W., Castronovo, V., & Waltregny, D. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.016 · Cited by 153
HDAC6 Deacetylates and Ubiquitinates MSH2 to Maintain Proper Levels of MutSα
Zhang, M., Xiang, S., Joo, H.-Y., Wang, L., Williams, K. A., Liu, W., Hu, C., Tong, D., Haakenson, J., Wang, C., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.028 · Cited by 151
“Previously, a class III HDAC, SirT2, was shown to deacetylate a-tubulin (North et al., 2003), which is an HDAC6 substrate (Hubbert et al., 2002).”
KIF19A Is a Microtubule-Depolymerizing Kinesin for Ciliary Length Control
Niwa, S., Nakajima, K., Miki, H., Minato, Y., Wang, D., & Hirokawa, N. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.10.016 · Cited by 166
“Tubulin-modifying enzymes, other microtubule depolymerases, and the ubiqutin-proteasome system are good candidates for cooperative depolymerization of stabilized axonemes (Huang et al., 2009; Hubbert et al., 2002; O’Hagan et al., 2011; Piao et al., 2009; Sharma et al., 2007).”
Youn, G. S., Lee, K., Choi, S. Y., & Park, J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.014 · Cited by 153
Carta, S., Tassi, S., Semino, C., Fossati, G., Mascagni, P., Dinarello, C. A., & Rubartelli, A. (2006) · Blood · doi:10.1182/blood-2006-03-014126 · Cited by 152
“Deacetylation of both proteins is mediated by HDAC6, which acts cytoplasmically.(25,26) In addition, α-tubulin is a target of the NADdependent histone deacetylase SIRT2.”
BackgroundHistone deacetylase 11 is an ε-N-Myristoyllysine hydrolase
Moreno-Yruela, C., Galleano, I., Madsen, A. S., & Olsen, C. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.04.007 · Cited by 149
Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
Guerrant, W., Patil, V., Canzoneri, J. C., & Oyelere, A. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm200799p · Cited by 143
Development of histone deacetylase inhibitors for cancer treatment
Marchion, D., & Münster, P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.583 · Cited by 149
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints
Warrener, R., Beamish, H., Burgess, A., Waterhouse, N. J., Giles, N., Fairlie, D. P., & Gabrielli, B. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-1003fje · Cited by 149
“The acetylation of acetyl lysine 40 α-tubulin has implications for microtubule stability and function (18, 30).”
BackgroundEspallergues, J., Teegarden, S. L., Veerakumar, A., Boulden, J., Challis, C., Jochems, J., Chan, M., Petersen, T., Deneris, E., Matthias, P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5634-11.2012 · Cited by 145
“These results extend to the brain a number of previous observations indicative of a limited contribution of HDAC6 to chromatin regulation (Hubbert et al., 2002).”
BackgroundResultMa, P., Pan, H., Montgomery, R. L., Olson, E. N., & Schultz, R. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118403109 · Cited by 145
“HDACs catalyze deacetylation of histones and many other nonhistone proteins such as tubulin (9) and transcription factors, e.”
BackgroundWang, G., Chen, Q., Zhang, X., Zhang, B., Zhuo, X., Liu, J., Jiang, Q., & Zhang, C. (2013) · Journal of Cell Science · doi:10.1242/jcs.114918 · Cited by 146
“HDAC6 is a tubulin deacetylase that functions in modulating cell spreading and motility, as well as primary cilia resorption (Hubbert et al., 2002; Pugacheva et al., 2007; Zhang et al., 2007).”
BackgroundCharacterization of the two catalytic domains in histone deacetylase 6
Zou, H., Wu, Y., Navre, M., & Sang, B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.144 · Cited by 148
Mai, A., Rotili, D., Tarantino, D., Ornaghi, P., Tosi, F., Vicidomini, C., Sbardella, G., Nebbioso, A., Miceli, M., Altucci, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060601m · Cited by 144
Liu, Y., Peng, L., Seto, E., Huang, S., & Qiu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371120 · Cited by 142
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Dickinson, M., Johnstone, R. W., & Prince, H. M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9596-y · Cited by 144
“HDAC6 warrants special attention as a HDAC predominantly, [11, 12] but not exclusively [9] localized to the”
BackgroundBates, E. A., Victor, M., Jones, A. K., Shi, Y., & Hart, A. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3344-05.2006 · Cited by 144
“HDA-3 loss suppresses CREB modulation Htn-Q150-induced degeneration Histone deacetylases are critical for transcriptional regulation, but HDACs are not limited to histones as targets (Hubbert et al., 2002).”
BackgroundThe emerging role of the tubulin code: From the tubulin molecule to neuronal function and disease
Chakraborti, S., Natarajan, K., Curiel, J., Janke, C., & Liu, J. (2016) · Cytoskeleton · doi:10.1002/cm.21290 · Cited by 143
“Acetylation of K40 is catalyzed by the enzyme aTAT1 [Akella et al., 2010; Shida et al., 2010; Szyk et al., 2014], and removed by HDAC6 [Hubbert et al., 2002] or SIR2 [North et al., 2003].”
BackgroundRegulation of the HIF-1α stability by histone deacetylases
Kim, S.-H., Jeong, J.-W., Park, J., Lee, J.-W., Seo, J., Jung, B.-K., Bae, M.-K., & Kim, K.-W. (2007) · Oncology Reports · doi:10.3892/or.17.3.647 · Cited by 144
The Diversity of Histone Versus Nonhistone Sirtuin Substrates
Martínez‐Redondo, P., & Vaquero, A. (2013) · Genes & Cancer · doi:10.1177/1947601913483767 · Cited by 160
HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
Yang, M. H., Laurent, G., Bause, A. S., Spang, R., German, N., Haigis, M. C., & Haigis, K. M. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0040-t · Cited by 141
“Although HDAC6 was first identified as a tubulin deacetylase (10-12), it has many other”
BackgroundMicrotubule Deacetylases, SirT2 and HDAC6, in the Nervous System
Southwood, C. M., Peppi, M., Dryden, S. C., Tainsky, M. A., & Gow, A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9127-6 · Cited by 144
“For SirT2 and HDAC6, which are cytoplasmic proteins, the best characterized substrate is the a-tubulin subunit of microtubules [11, 12, 22].”
Park, J., Jung, Y., Kim, T. Y., Kim, S. G., Jong, H.-S., Lee, S. E., Kim, D.-K., Lee, J., Kim, N. K., Kim, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0709 · Cited by 143
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Dallol, A., Agathanggelou, A., Fenton, S. L., Ahmed-Choudhury, J., Hesson, L. B., Vos, M. D., Clark, G., Downward, J., Maher, E. R., & Latif, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0267 · Cited by 146
Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy
Spiegel, S., Milstien, S., & Grant, S. (2012) · Oncogene · doi:10.1038/onc.2011.267 · Cited by 141
“Specific inhibitors of HDAC6 such as tubacin have been shown to interact synergistically with proteasome inhibitors such as bortezomib to kill multiple myeloma and Burkitt’s lymphoma cells (Kawada et al., 2009).”
InfluentialDevelopment of a histone deacetylase 6 inhibitor and its biological effects
Lee, J.-H., Mahendran, A., Yao, Y., Ngo, L., Venta-Perez, G., Choy, M. L., Kim, N., Ham, W.-S., Breslow, R., & Marks, P. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313893110 · Cited by 141
Kim, G.-W., Li, L., Gorbani, M., You, L., & Yang, X.-J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.464792 · Cited by 141
Fiskus, W., Ren, Y., Mohapatra, A., Bali, P., Mandawat, A., Rao, R., Herger, B., Yang, Y., Atadja, P., Wu, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3093 · Cited by 140
Suzuki, J., Chen, Y.-Y., Scott, G. K., DeVries, S., Chin, K., Benz, C. C., Waldman, F. M., & Hwang, E. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2319 · Cited by 141
The Tale of Protein Lysine Acetylation in the Cytoplasm
Sadoul, K., Wang, J., Diagouraga, B., & Khochbin, S. (2011) · BioMed Research International · doi:10.1155/2011/970382 · Cited by 140
“While it has been suggested that acetylation just accumulates with time in microtubules with a long half-life [108], others have proposed that acetylation could directly stabilise microtubules [50, 51].”
BackgroundSelenica, M.-L., Benner, L., Housley, S. B., Manchec, B., Lee, D. C., Nash, K. R., Kalin, J., Bergman, J. A., Kozikowski, A., Gordon, M. N., et al. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt241 · Cited by 140
“Measurements of αtubulin acetylation were used to determine the efficacy of the treatment in modifying the acetylation state of αtubulin at the Lys40 residue.”
BackgroundInfluentialAcetylation Goes Global: The Emergence of Acetylation Biology
Norris, K. L., Lee, J.-Y., & Yao, T.-P. (2009) · Science Signaling · doi:10.1126/scisignal.297pe76 · Cited by 139
Self-citationNusinzon, I., & Horvath, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3106-3113.2006 · Cited by 139
“HDAC6 can also regulate distribution of T-cell receptor components during assembly of the immunological synapse between T cells and antigen-presenting cells (5, 9, 10).”
BackgroundBack to the tubule: microtubule dynamics in Parkinson’s disease
Pellegrini, L., Wetzel, A., Grannó, S., Heaton, G., & Harvey, K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2351-6 · Cited by 137
The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
Roos, W. P., & Krumm, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw922 · Cited by 139
“HDAC6 is predominantly found in the cytoplasm of cells (91,92), but upon the induction of DNA damage (89) or differentiation (93), a fraction of HDAC6 becomes nuclear.”
BackgroundHDAC6 a new cellular stress surveillance factor
Matthias, P., Yoshida, M., & Khochbin, S. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5186 · Cited by 139
Self-citationAssembly of the SMRT–histone deacetylase 3 repression complex requires the TCP-1 ring complex
Guenther, M. G., Yu, J., Kao, G. D., Yen, T. J., & Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.1037502 · Cited by 138
“2001) and can influence microtubule-dependent cell motility by deacetylation of -tubulin (Hubbert et al. 2002).”
BackgroundWoan, K. V., Lienlaf, M., Perez-Villaroel, P., Lee, C., Cheng, F., Knox, T., Woods, D. M., Barrios, K., Powers, J., Sahakian, E., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.002 · Cited by 137
Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies
Qian, X., LaRochelle, W. J., Ara, G., Wu, F. S.-Y., Petersen, K. D., Thougaard, A., Sehested, M., Lichenstein, H. S., & Jeffers, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0111 · Cited by 139
Histone deacetylase inhibitors: insights into mechanisms of lethality
Rosato, R. R., & Grant, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.809 · Cited by 136
“This activity is specifically inhibited by TSA and tubacin [191-193].”
BackgroundGlobal Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
Ashktorab, H., Belgrave, K., Hosseinkhah, F., Brim, H., Nouraie, M., Takkikto, M., Hewitt, S., Lee, E. L., Dashwood, R. H., & Smoot, D. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0601-7 · Cited by 137
HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
Li, G., Jiang, H., Chang, M., Xie, H., & Hu, L. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.017 · Cited by 160
“So far the best characterized interaction with a substrate is with the α-tubulin subunit of microtubules [15,17].”
BackgroundHDAC signaling in neuronal development and axon regeneration
Cho, Y., & Cavalli, V. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.008 · Cited by 135
“HDAC6 expression is mostly cytoplasmic and was the first identified tubulin deacetylase [5].”
BackgroundSong, C., Zhu, S., Wu, C., & Kang, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498758 · Cited by 145
Law, B. M. H., Spain, V. A., Leinster, V. H. L., Chia, R., Beilina, A., Cho, H. J., Taymans, J.-M., Urban, M. K., Sancho, R. M., Ramírez, M. B., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507913 · Cited by 135
Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
Huang, P., Almeciga-Pinto, I., Jarpe, M., van Duzer, J. H., Mazitschek, R., Yang, M., Jones, S. S., & Quayle, S. N. (2017) · Oncotarget · doi:10.18632/oncotarget.13738 · Cited by 130
“Amongst many known regulators of α-tubulin posttranslational modification, histone deacetylase (HDAC) 6 is the major deacetylase of lysine-40 [17].”
Lee, J.-Y., Kapur, M., Li, M., Choi, M.-C., Choi, S., Kim, H.-J., Kim, I., Lee, E., Taylor, J. P., & Yao, T.-P. (2014) · Journal of Cell Science · doi:10.1242/jcs.157321 · Cited by 133
Self-citationChen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 132
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.